Peter Ordentlich

Insider Reports History

Location
Waltham, MA
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Ordentlich:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Chief Scientific Officer Common Stock 0 $18.27 15 Feb 2023 Direct
Syndax Pharmaceuticals Inc Chief Scientific Officer Stock Options (Right to buy) 0 $19.35 15 Feb 2023 Direct

Insider Reports Filed by Peter Ordentlich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNDX Syndax Pharmaceuticals Inc 15 Feb 2023 6 -$1,118,394 4 Chief Scientific Officer 17 Feb 2023, 17:09
SNDX Syndax Pharmaceuticals Inc 31 Jan 2023 3 +$2,568,734 4 Chief Scientific Officer 03 Feb 2023, 15:59
SNDX Syndax Pharmaceuticals Inc 01 Dec 2022 9 -$466,638 4 Chief Scientific Officer 02 Dec 2022, 16:01
SNDX Syndax Pharmaceuticals Inc 29 Jul 2022 7 -$464,086 4 Chief Scientific Officer 26 Aug 2022, 16:14
SNDX Syndax Pharmaceuticals Inc 01 Feb 2022 3 +$1,257,185 4 Chief Scientific Officer 03 Feb 2022, 16:32